Company M. Basic Pharmaceuticals Srl with Fiscal Code 36224815
recorded a turnover of 2024 of
- ,
with a net profit of
-130
and having an average number of employees of
- .
The company operates in the field of Fabricarea preparatelor farmaceutice having the NACE code 2120.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
M. Basic Pharmaceuticals Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
0
48.117
64.196
61.523
3.057
55.668
0
0
0
Total Income - EUR
-
0
96.195
109.913
98.899
6.928
90.010
4.333
0
0
Total Expenses - EUR
-
416
53.696
50.488
41.521
2.156
44.150
129
14
130
Gross Profit/Loss - EUR
-
-416
42.499
59.425
57.377
4.772
45.860
4.204
-14
-130
Net Profit/Loss - EUR
-
-416
40.987
57.497
55.527
4.680
44.387
4.077
-14
-130
Employees
-
0
0
0
0
0
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Check the financial reports for the company - M. Basic Pharmaceuticals Srl
Financial Rating - M. BASIC PHARMACEUTICALS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - M. Basic Pharmaceuticals Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - M. Basic Pharmaceuticals Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - M. Basic Pharmaceuticals Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
M. Basic Pharmaceuticals Srl - CUI 36224815
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
145
142
140
137
0
0
0
0
0
Current Assets
-
63
41.806
25.686
79.949
26.759
70.518
4.142
4.100
3.947
Inventories
-
0
0
0
0
0
1
0
0
0
Receivables
-
0
0
0
0
2.322
111
0
74
74
Cash
-
63
41.806
25.686
79.949
24.437
70.406
4.142
4.026
3.873
Shareholders Funds
-
-371
40.622
20.464
75.595
22.262
66.155
4.126
4.100
3.947
Social Capital
-
45
44
43
42
41
40
41
40
40
Debts
-
579
1.326
5.361
4.491
4.498
4.362
16
0
0
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"2120 - 2120"
CAEN Financial Year
2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
3.947 euro in 2024 which includes Inventories of
0 euro, Receivables of
74 euro and cash availability of
3.873 euro.
The company's Equity was valued at
3.947 euro, while total Liabilities amounted to
0 euro.
Equity decreased by -130 euro, from 4.100 euro in 2023, to 3.947 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - M. Basic Pharmaceuticals Srl